These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 29908870)

  • 21. A potential therapeutic strategy for inhibition of corneal neovascularization with new anti-VEGF agents.
    Hosseini H; Nejabat M
    Med Hypotheses; 2007; 68(4):799-801. PubMed ID: 17107753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Mechanisms of corneal neovascularization and modern options for its suppression].
    Mamikonyan VR; Pivin EA; Krakhmaleva DA
    Vestn Oftalmol; 2016; 132(4):81-87. PubMed ID: 28635927
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Estrella-Mendoza MF; Jiménez-Gómez F; López-Ornelas A; Pérez-Gutiérrez RM; Flores-Estrada J
    Nutrients; 2019 May; 11(5):. PubMed ID: 31137826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting corneal inflammation by gene therapy: Emerging strategies for keratitis.
    Torrecilla J; Del Pozo-Rodríguez A; Vicente-Pascual M; Solinís MÁ; Rodríguez-Gascón A
    Exp Eye Res; 2018 Nov; 176():130-140. PubMed ID: 29981344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization.
    Luis de Redín I; Boiero C; Recalde S; Agüeros M; Allemandi D; Llabot JM; García-Layana A; Irache JM
    Exp Eye Res; 2019 Aug; 185():107697. PubMed ID: 31228461
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anti-VEGF Treatment of Corneal Neovascularization.
    Keating AM; Jacobs DS
    Ocul Surf; 2011 Oct; 9(4):227-37. PubMed ID: 22023817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal neovascularization: molecular events and therapeutic options.
    Shakiba Y; Mansouri K; Arshadi D; Rezaei N
    Recent Pat Inflamm Allergy Drug Discov; 2009 Nov; 3(3):221-31. PubMed ID: 19702562
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinico-biochemical correlation of the effect of subconjunctival bevacizumab for corneal neovascularization.
    Agarwal S; Angayarkanni N; Iyer G; Srinivasan B; Natarajan R; Charola S; Arumugam S; Padmanabhan P
    Cornea; 2014 Oct; 33(10):1016-21. PubMed ID: 25090164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of subconjunctival ranibizumab on corneal and anterior segment neovascularization: study on an animal model.
    Liarakos VS; Papaconstantinou D; Vergados I; Douvali M; Theodossiadis PG
    Eur J Ophthalmol; 2014; 24(3):299-308. PubMed ID: 24242219
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of COX inhibitors on VEGF-induced retinal vascular leakage and experimental corneal and choroidal neovascularization.
    Castro MR; Lutz D; Edelman JL
    Exp Eye Res; 2004 Aug; 79(2):275-85. PubMed ID: 15325574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Corneal Fine Needle Diathermy With Adjuvant Bevacizumab to Treat Corneal Neovascularization in Children.
    Elbaz U; Mireskandari K; Shen C; Ali A
    Cornea; 2015 Jul; 34(7):773-7. PubMed ID: 25811720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of pirfenidone in alkali burn rat cornea.
    Jiang N; Ma M; Li Y; Su T; Zhou XZ; Ye L; Yuan Q; Zhu P; Min Y; Shi W; Xu X; Lv J; Shao Y
    Int Immunopharmacol; 2018 Nov; 64():78-85. PubMed ID: 30153530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of KH902 in inhibiting suture induced corneal neovascularization].
    Wang F; Deng YP; Zhang M
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 May; 45(3):419-23. PubMed ID: 24941809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genome-wide expression datasets of anti-VEGF and dexamethasone treatment of angiogenesis in the rat cornea.
    Mukwaya A; Mirabelli P; Lennikov A; Xeroudaki M; Schaupper M; Peebo B; Lagali N
    Sci Data; 2017 Aug; 4():170111. PubMed ID: 28809847
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and ocular safety of intravitreal anti-VEGF therapies for ocular neovascular disease.
    Tolentino M
    Surv Ophthalmol; 2011; 56(2):95-113. PubMed ID: 21335144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Angioregressive pretreatment of mature corneal blood vessels before keratoplasty: fine-needle vessel coagulation combined with anti-VEGFs.
    Koenig Y; Bock F; Kruse FE; Stock K; Cursiefen C
    Cornea; 2012 Aug; 31(8):887-92. PubMed ID: 22362005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Inhibition of corneal neovascularization by vascular endothelial growth inhibitor gene].
    Wang B; Wang CF; Wang LH; Pang Q
    Zhonghua Yan Ke Za Zhi; 2008 Oct; 44(10):929-33. PubMed ID: 19176123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of sunitinib and bevacizumab on VEGF and miRNA levels on corneal neovascularization.
    Cakmak H; Gokmen E; Bozkurt G; Kocaturk T; Ergin K
    Cutan Ocul Toxicol; 2018 Jun; 37(2):191-195. PubMed ID: 28874077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Requirement for vascular endothelial growth factor in wound- and inflammation-related corneal neovascularization.
    Amano S; Rohan R; Kuroki M; Tolentino M; Adamis AP
    Invest Ophthalmol Vis Sci; 1998 Jan; 39(1):18-22. PubMed ID: 9430540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subconjunctival injection of bevacizumab (avastin) on corneal neovascularization in different rabbit models of corneal angiogenesis.
    Chen WL; Lin CT; Lin NT; Tu IH; Li JW; Chow LP; Liu KR; Hu FR
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1659-65. PubMed ID: 18997093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.